
|Articles|July 25, 2013
Session 1: Discussant
Author(s)William H. Herman, MD, MPH
In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective.
Advertisement
In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective. "There is no one-size-fits-all measure of diabetes quality or glycemic care," said Dr Herman. Dr Herman also discussed his viewpoint as a clinical endocrinologist diabetologist. "So patients who are remarkably likely to have targets I think the targets were appropriately modified based on risk of hypoglycemia," said Herman. "I do have general concern that maybe the targets are even too low based on the evidence."
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
2
INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD
3
First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD
4
AI Reshaping Diabetes Care From Nutrition to Clinical Decisions
5



